Spyre Therapeutics (SYRE) Net Equity Issued and Repurchased (2015 - 2024)
Spyre Therapeutics' (SYRE) quarterly Net Equity Issued and Repurchased came in at -$157.3 million in Q3 2024, down 116425.93% on a QoQ basis from -$135000.0 in Q2 2024.
Spyre Therapeutics (SYRE) Net Equity Issued and Repurchased (2015 - 2024) Analysis & Trends
Spyre Therapeutics (SYRE) has 5 years of Net Equity Issued and Repurchased data on file, last reported at -$157.3 million in Q3 2024.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$157.3 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $209.1 million (changed N/A YoY) and the FY2023 annual result came in at $197.4 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased eased to -$157.3 million in Q3 2024, from -$135000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $197.4 million in Q4 2023 to a low of -$157.3 million in Q3 2024.
- A 3-year average of $46.7 million and a median of $24.6 million in 2020 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Spyre Therapeutics | 9.13 Bn | 9.13 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -157.31 Mn |
| Sep 30, 2024 | -157.31 Mn |
| Jun 30, 2024 | -135,000.00 |
| Jun 30, 2024 | -135,000.00 |
| Mar 31, 2024 | 169.21 Mn |
| Mar 31, 2024 | 169.21 Mn |
| Dec 31, 2023 | 197.36 Mn |
| Dec 31, 2023 | 197.36 Mn |
| Dec 31, 2020 | 24.60 Mn |
| Dec 31, 2020 | 24.60 Mn |
| Mar 31, 2017 | 96,000.00 |
| Mar 31, 2017 | 96,000.00 |
| Sep 30, 2015 | -5,000.00 |
| Sep 30, 2015 | -5,000.00 |
| Jun 30, 2015 | 6,000.00 |
| Jun 30, 2015 | 6,000.00 |
| Mar 31, 2015 | 43.68 Mn |
| Mar 31, 2015 | 43.68 Mn |